EAM
ITCI
EFG Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-74,190
| Closed | -$6.2M | – | 196 |
|
|
2024
Q4 | $6.2M | Buy |
74,190
+37,061
| +100% | +$3.1M | 0.85% | 24 |
|
|
2024
Q3 | $2.72M | Buy |
37,129
+2,677
| +8% | +$196K | 0.45% | 86 |
|
|
2024
Q2 | $2.36M | Buy |
34,452
+163
| +0.5% | +$11.2K | 0.41% | 92 |
|
|
2024
Q1 | $2.37M | Buy |
34,289
+1,935
| +6% | +$134K | 0.41% | 93 |
|
|
2023
Q4 | $2.32M | Sell |
32,354
-804
| -2% | -$57.6K | 0.44% | 86 |
|
|
2023
Q3 | $1.73M | Buy |
33,158
+837
| +3% | +$43.6K | 0.41% | 84 |
|
|
2023
Q2 | $2.05M | Sell |
32,321
-1,912
| -6% | -$121K | 0.44% | 72 |
|
|
2023
Q1 | $1.85M | Sell |
34,233
-1,917
| -5% | -$104K | 0.41% | 80 |
|
|
2022
Q4 | $1.94M | Sell |
36,150
-1,214
| -3% | -$65K | 0.43% | 80 |
|
|
2022
Q3 | $1.74M | Sell |
37,364
-2,811
| -7% | -$131K | 0.4% | 91 |
|
|
2022
Q2 | $2.29M | Buy |
40,175
+1,450
| +4% | +$82.8K | 0.48% | 71 |
|
|
2022
Q1 | $2.37M | Sell |
38,725
-346
| -0.9% | -$21.2K | 0.36% | 88 |
|
|
2021
Q4 | $2.04M | Buy |
+39,071
| New | +$2.04M | 0.27% | 110 |
|